After completing 12 months romosozumab, what is the next best treatment option for patients with severe osteoporosis, high risk for fracture, and normal kidney function?

Community
Company
News
Contact Us
Sign in

Topics: Rheumatology • Osteoporosis • Endocrinology • Bone and Calcium Disorders

Answer from: at Community Practice

Zoledronic acid is my clear-cut first choice in this setting.

21089

Related Questions

Would you use romosozumab in a patient with a cardiovascular event more than 2 years prior?

What is your approach to managing osteoporosis in patients with end stage kidney disease?

How do you reduce the risk of contralateral fracture in a patient with atypical femur fracture from prolonged bisphosphonate use?

How would you approach a finding of osteoporosis (Z score -4.5) in a recently postpartum patient who had DEXA sent for long term low-dose glucocorticoid use?

Would you transition from denosumab to anabolic agents in patients who are in urgent need for extensive dental work?

How do you approach significant change in BMD in premenopausal patient on tamoxifen?

Would you consider anabolic osteoporosis therapy in a young adult male with multiple non-traumatic vertebral compression fractures and low bone density for age (Z-score -2.6)?

Do you recommend osteoporosis medication in postmenopausal females on anastrozole with very low Vitamin D (4.5)?

Have the results of the ancillary study of the VITAL trial, demonstrating that Vitamin D3 supplementation did not reduce the incident rate of fractures in generally healthy midlife and older adults, changed how you prescribe Vitamin D?

Would atypical fractures of the hip in a parent (treated with bisphosphonate) be considered when calculating the FRAX score for a patient with osteopenia?